Skip to content
Tuesday, November 17, 2026
Solar Betting Point

Users Discontinuing Slimming Injections Regain Pounds at a Quadrupled Rate Than Dieters

Illustration of pharmaceutical syringe and scale
Weight management often requires long-term strategies.

New research reveals that people who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who end conventional diet and exercise plans.

Research printed in a leading medical journal shows that while overweight individuals frequently drop substantial amounts of their body weight while on the medication, the mass returns at an average rate of 0.8 kg per month upon discontinuation.

"Individuals buying such drugs must be aware of the danger of fast weight regain when the treatment concludes," stated researcher Dr. Susan Jebb.

That rate of regain means a reversion to original weight within about a year and a half.

Comparing Treatments

The study, which examined 37 of trials involving thousands of patients, compared the effects of GLP-1 agonists with other pills.

Scientists note that individuals who lose weight through diet and exercise generally have a more gradual weight regain—around 0.1 kg a month—after stopping.

Understanding the Rapid Regain

Experts propose the mechanism of the drugs is key to understanding the accelerated weight return.

GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate hunger.

"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement leads to hunger is uncontrolled, making binge eating far more likely."

A Chronic Issue?

The NHS recommend the injections for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.

Many experts contend that, due to the high risk of relapse, the treatment might need to be ongoing.

This view is reinforced by pharmaceutical companies, who state that the findings "highlight the persistent nature of obesity," similar to managing diseases like high blood pressure.

Patient Experiences

Users who have discontinued the jabs describe a powerful return of appetite.

"It was like a trigger that goes on and you're instantly extremely hungry," recalled one woman.

The struggle is worsened if patients have not developed sustainable dietary or behavioural changes during treatment.

Significant Interest

Survey data show that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire being substantial.

  • Use is greater among women compared to men.
  • The middle-aged demographic shows the highest usage rates.
  • Many obtain the drugs through private prescriptions rather than the NHS.

In conclusion, clinicians stress that while the jabs are potent tools for shedding pounds, they are not a permanent solution and maintained weight loss likely depends on integrated lifestyle management.

Written by

Andrea Ross DDS

A financial analyst specializing in green energy markets, with over a decade of experience in renewable investment strategies.

Solar Betting Point

Type to search articles.